About Us

ACHIEVING MORe FOR RNA TREATMENTs

Our Story

Guided by our team of srRNA experts and with a customizable library of synthetic srRNA vectors and end-to-end development capabilities at our disposal, we are uniquely positioned to develop safe and effective srRNA immunotherapies that maximize impact for more patients.
Our story began in 2014
Replicate co-founders Nathaniel Wang, Ph.D. and Andy Geall, Ph.D. had spent years working together in RNA vaccine development.
An idea for a vector-driven platform
They started Replicate to answer the question, “If we wanted to create the best self-replicating RNA platform from scratch, how would we do it?”
Broadening applications
Joining with former colleagues Herbert Kim Lyerly, M.D., and Zachary Hartman, Ph.D., professors of cancer research and immunology at Duke University, the founding team began to explore preventing or removing drug-resistant cancer mutations using srRNA.
The work begins
Replicate exclusively licensed from Duke technology to prevent drug-resistant cancer mutations. Then we got to work building new vectors from scratch.
Today
We have since made rapid progress in identifying many promising srRNA preclinical candidates in infectious disease, oncology, and autoimmune diseases.
Learn more about our
srRNA platform
A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible. The background is teal and a white, curved light trail follows the path of the srRNA. A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible. The background is teal and a white, curved light trail follows the path of the srRNA.
A Replicate employee presents in front of a large screen of data. A Replicate employee presents in front of a large screen of data.
A scientist wearing lab goggles and black gloves holds a tray of pipetted liquid. A scientist wearing lab goggles and black gloves holds a tray of pipetted liquid.
Four Replicate employees smile and converse around a table. Four Replicate employees smile and converse around a table.
Want to be a part of the next revolution in RNA therapeutics?
A cut-out image of a scientist wearing lab goggles, black gloves, and a white lab coat inspecting a tube of orange liquid, superimposed over a light blue wave background with a white light trail. A cut-out image of a scientist wearing lab goggles, black gloves, and a white lab coat inspecting a tube of orange liquid, superimposed over a light blue wave background with a white light trail.